Literature DB >> 7362156

Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis.

S S Nair, J M Kaplan, L H Levine, K Geraci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7362156     DOI： 10.7326/0003-4819-92-4-511_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Cholestatic jaundice caused by trimethoprim.

Authors:  U K Singh; V K Singh
Journal:  Indian J Pediatr       Date:  1991 May-Jun       Impact factor: 1.967

2.  Tolvaptan-induced Liver Injury: Who is at Risk? A Case Report and Literature Review.

Authors:  Muhammad Y Khan; Muhammad Shabbir Rawala; Maryam Siddiqui; Waqas Abid; Aysha Aslam
Journal:  Cureus       Date:  2019-06-05

Review 3.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

4.  Sulfamethoxazole-induced hepatic injury.

Authors:  U P Steinbrecher; S Mishkin
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

5.  Co-trimoxazole-induced hepatic injury--an analysis of cases with hypersensitivity-like reactions.

Authors:  P A Berg; P T Daniel
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 6.  Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.

Authors:  Philip J Peters; Michael C Thigpen; Monica E Parise; Robert D Newman
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 7.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 8.  Severe and prolonged cholestasis caused by trimethoprim-sulfamethoxazole: a case report.

Authors:  Luciana C Faria; Clarissa C Resende; Cláudia A Couto; Osvaldo F M Couto; Lúcia P C Fonseca; Teresa Cristina A Ferrari
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.